MYL News and Press, Mylan N.V. From 09/08/20

HERTFORDSHIRE, England , and PITTSBURGH , Sept. 8, 2020 /PRNewswire/ --  Mylan  N.V. (NASDAQ: MYL) today announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe ...

Mylan N.V. (NASDAQ: MYL ) and Biocon Biologics India, a subsidiary of Biocon Ltd. ( OTC:BCNQY ) announce the U.S. launch of Semglee (insulin glargine injection) in vial and pre-filled pen to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults w...

HERTFORDSHIRE, England and PITTSBURGH and BENGALURU, India , Aug. 31, 2020 /PRNewswire/ --  Mylan N.V.  (NASDAQ: MYL) and Biocon Biologics India Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today announced the U.S. launch of Semglee™ (insulin ...

HERTFORDSHIRE, England and PITTSBURGH , Aug. 28, 2020 /PRNewswire/ -- Mylan N.V.  (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl Injection, U...

Eli Lilly (NYSE: LLY) and Pfizer (NYSE: PFE) are two of several pharma giants in the race to combat COVID-19. Eli Lilly is currently evaluating three potential therapies for the disease in clinical trials, while Pfizer has kicked off a phase 3 study for its lead COVID-19 vaccine candidat...

One of the most common reasons people don't start a stock portfolio is that they think they can't afford to invest. While some stocks may not be attainable buys with a smaller starting amount, you can still build your portfolio with a modest initial investment and set yourself up for healthy fut...

Change Healthcare acquires medical imaging platform Nucleus.io Change Healthcare ( CHNG ) announced that it has acquired Nucleus.io, a leading imaging company. The company looks to augment its medical imaging portfolio with this acquisition. Nucleus.io is believed to have more than 7,500...

Aquestive Therapeutics (NASDAQ: AQST ) initiates a Phase 1 clinical trial in 28 healthy volunteers evaluating the safety and pharmacokinetics (PK) of AQST-108, an oral sublingual formulation of epinephrine, for the potential treatment of allergic reactions, including anaphylaxis (ac...

This article is part of a series that provides an ongoing analysis of the changes made to John Paulson's 13F stock portfolio on a quarterly basis. It is based on Paulson's regulatory 13F Form filed on 08/14/2020. Please visit our Tracking John Paulson's Paulson & Company Portfolio serie...

Mylan N.V. (NASDAQ: MYL ) announces  the launch of the first FDA-approved therapeutically equivalent, substitutable generic of Biogen's Tecfidera capsules. More news on: Mylan, Inc., Healthcare stocks news, Read more ...